Biotechnology
Compare Stocks
2 / 10Stock Comparison
APM vs IQV
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Diagnostics & Research
APM vs IQV — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Biotechnology | Medical - Diagnostics & Research |
| Market Cap | $5M | $30.32B |
| Revenue (TTM) | $431K | $16.63B |
| Net Income (TTM) | $-7M | $1.39B |
| Gross Margin | -318.7% | 26.1% |
| Operating Margin | -33.5% | 13.9% |
| Forward P/E | — | 14.1x |
| Total Debt | $3M | $16.17B |
| Cash & Equiv. | $874K | $1.98B |
APM vs IQV — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Aptorum Group Limit… (APM) | 100 | 2.7 | -97.3% |
| IQVIA Holdings Inc. (IQV) | 100 | 119.5 | +19.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: APM vs IQV
Each card shows where this stock fits in a portfolio — not just who wins on paper.
In this particular matchup, APM is outpaced on most metrics by others in the set.
IQV carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 1.33
- Rev growth 5.9%, EPS growth 4.7%, 3Y rev CAGR 4.2%
- 166.5% 10Y total return vs APM's -99.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.9% revenue growth vs APM's -100.0% | |
| Quality / Margins | 8.3% margin vs APM's -16.4% | |
| Stability / Safety | Beta 1.33 vs APM's 1.60 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +16.5% vs APM's -5.6% | |
| Efficiency (ROA) | 4.7% ROA vs APM's -44.0%, ROIC 8.7% vs -18.3% |
APM vs IQV — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
APM vs IQV — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
IQV leads this category, winning 5 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
IQV is the larger business by revenue, generating $16.6B annually — 38555.5x APM's $431,378. IQV is the more profitable business, keeping 8.3% of every revenue dollar as net income compared to APM's -16.4%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $431,378 | $16.6B |
| EBITDAEarnings before interest/tax | -$13M | $3.5B |
| Net IncomeAfter-tax profit | -$7M | $1.4B |
| Free Cash FlowCash after capex | -$9M | $2.7B |
| Gross MarginGross profit ÷ Revenue | -3.2% | +26.1% |
| Operating MarginEBIT ÷ Revenue | -33.5% | +13.9% |
| Net MarginNet income ÷ Revenue | -16.4% | +8.3% |
| FCF MarginFCF ÷ Revenue | -20.8% | +16.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +8.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -156.9% | +15.0% |
Valuation Metrics
APM leads this category, winning 2 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $5M | $30.3B |
| Enterprise ValueMkt cap + debt − cash | $7M | $44.5B |
| Trailing P/EPrice ÷ TTM EPS | -1.08x | 22.79x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 14.06x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.56x |
| EV / EBITDAEnterprise value multiple | — | 12.97x |
| Price / SalesMarket cap ÷ Revenue | — | 1.86x |
| Price / BookPrice ÷ Book value/share | 0.39x | 4.67x |
| Price / FCFMarket cap ÷ FCF | — | 14.78x |
Profitability & Efficiency
IQV leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
IQV delivers a 22.1% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $-60 for APM. APM carries lower financial leverage with a 0.28x debt-to-equity ratio, signaling a more conservative balance sheet compared to IQV's 2.44x. On the Piotroski fundamental quality scale (0–9), IQV scores 4/9 vs APM's 1/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -60.2% | +22.1% |
| ROA (TTM)Return on assets | -44.0% | +4.7% |
| ROICReturn on invested capital | -18.3% | +8.7% |
| ROCEReturn on capital employed | -25.0% | +11.0% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 4 |
| Debt / EquityFinancial leverage | 0.28x | 2.44x |
| Net DebtTotal debt minus cash | $2M | $14.2B |
| Cash & Equiv.Liquid assets | $874,238 | $2.0B |
| Total DebtShort + long-term debt | $3M | $16.2B |
| Interest CoverageEBIT ÷ Interest expense | -30.72x | 3.10x |
Total Returns (Dividends Reinvested)
IQV leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IQV five years ago would be worth $7,621 today (with dividends reinvested), compared to $337 for APM. Over the past 12 months, IQV leads with a +16.5% total return vs APM's -5.6%. The 3-year compound annual growth rate (CAGR) favors IQV at -2.0% vs APM's -38.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -21.5% | -20.7% |
| 1-Year ReturnPast 12 months | -5.6% | +16.5% |
| 3-Year ReturnCumulative with dividends | -76.9% | -5.9% |
| 5-Year ReturnCumulative with dividends | -96.6% | -23.8% |
| 10-Year ReturnCumulative with dividends | -99.4% | +166.5% |
| CAGR (3Y)Annualised 3-year return | -38.7% | -2.0% |
Risk & Volatility
IQV leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
IQV is the less volatile stock with a 1.33 beta — it tends to amplify market swings less than APM's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IQV currently trades 72.3% from its 52-week high vs APM's 18.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.60x | 1.33x |
| 52-Week HighHighest price in past year | $4.47 | $247.05 |
| 52-Week LowLowest price in past year | $0.65 | $134.65 |
| % of 52W HighCurrent price vs 52-week peak | +18.8% | +72.3% |
| RSI (14)Momentum oscillator 0–100 | 45.2 | 58.5 |
| Avg Volume (50D)Average daily shares traded | 51K | 1.6M |
Analyst Outlook
IQV leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $225.63 |
| # AnalystsCovering analysts | — | 44 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 1 | 2 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +4.1% |
IQV leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). APM leads in 1 (Valuation Metrics).
APM vs IQV: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is APM or IQV a better buy right now?
For growth investors, IQVIA Holdings Inc.
(IQV) is the stronger pick with 5. 9% revenue growth year-over-year, versus -100. 0% for Aptorum Group Limited (APM). IQVIA Holdings Inc. (IQV) offers the better valuation at 22. 8x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate IQVIA Holdings Inc. (IQV) a "Buy" — based on 44 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — APM or IQV?
Over the past 5 years, IQVIA Holdings Inc.
(IQV) delivered a total return of -23. 8%, compared to -96. 6% for Aptorum Group Limited (APM). Over 10 years, the gap is even starker: IQV returned +166. 5% versus APM's -99. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — APM or IQV?
By beta (market sensitivity over 5 years), IQVIA Holdings Inc.
(IQV) is the lower-risk stock at 1. 33β versus Aptorum Group Limited's 1. 60β — meaning APM is approximately 20% more volatile than IQV relative to the S&P 500. On balance sheet safety, Aptorum Group Limited (APM) carries a lower debt/equity ratio of 28% versus 2% for IQVIA Holdings Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — APM or IQV?
By revenue growth (latest reported year), IQVIA Holdings Inc.
(IQV) is pulling ahead at 5. 9% versus -100. 0% for Aptorum Group Limited (APM). On earnings-per-share growth, the picture is similar: IQVIA Holdings Inc. grew EPS 4. 7% year-over-year, compared to -25. 8% for Aptorum Group Limited. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — APM or IQV?
IQVIA Holdings Inc.
(IQV) is the more profitable company, earning 8. 3% net margin versus -1644. 3% for Aptorum Group Limited — meaning it keeps 8. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IQV leads at 14. 0% versus -33. 5% for APM. At the gross margin level — before operating expenses — IQV leads at 26. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — APM or IQV?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is APM or IQV better for a retirement portfolio?
For long-horizon retirement investors, IQVIA Holdings Inc.
(IQV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+166. 5% 10Y return). Aptorum Group Limited (APM) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IQV: +166. 5%, APM: -99. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between APM and IQV?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.